The AML Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Spliceosome mutations

Spliceosome mutations

Around 10% of patients with AML have mutations in splicing factors, such as SRSF2, U2AF1, SF3B1, and ZRSR2. These patients tend to be older and have less proliferative disease. These mutations are believed to cause the missplicing of genes involved in epigenetic regulation, transcription, and genome integrity.

| | |